We are international

Myeloma Minute
May 22, 2014

May 22, 2014

Share the Minute



Clinical Trials

Donate to the IMF



This week's question: Are PET/CT scans useful for a patient with MGUS?


Thursday, June 26, 2014
4 pm PT/ 7 pm ET
Post ASCO/EHA/IMWG Teleconference
Hosted by Dr. Durie

Saturday, June 7, 2014
7th Annual Carolyn Czerkies
Memorial Golf Outing

Joliet, Illinois

Saturday, June 14, 2014
Myeloma Center Workshop
Minneapolis, Minnesota


The Future of Virotherapy for Myeloma Patients: Next Steps

IMF Chairman Dr. Brian Durie spoke with Dr. Stephen Russell of the Mayo Clinic this week about the news that 50-year-old myeloma patient Stacy Erholtz, who was treated with a massive dose of engineered measles virus in his clinical trial, had experienced a complete remission. What are the ramifications of this successful systemic breakthrough? What are the caveats? And which other viruses might be effective in destroying myeloma? Click HERE to read Dr. Durie's blog on this exciting myeloma treatment development.

FDA Grants Elotuzumab Breakthrough Therapy Status

This week, the US FDA granted elotuzumab breakthrough therapy status — a designation intended to expedite the development and FDA review of promising drugs for life-threatening conditions. Elotuzumab, a monoclonal antibody from Bristol-Myers Squibb and AbbVie, used in combination with lenalidomide and dexamethasone, produced remarkably durable responses, according to data presented at ASCO in 2013. "We'll be very keen to see the results from the latest studies that will be presented in June at the 2014 congress of the European Hematology Association," said Dr. Brian Durie. CLICK HERE to watch an IMF video in which Dr. Sagar Lonial of the Winship Cancer Institute of Emory University discusses the phase II trial that supported elotuzumab's breakthrough therapy designation.

Join 40,000+ Viewers Who Get the Latest Myeloma News from IMF's Conference Series!

Be among the first to learn the latest myeloma news presented at the 2014 International Myeloma Working Group (IMWG) Summit and the European Hematology Association (EHA) Congress in Milan, Italy. Just register for the IMF's popular IMWG Conference Series, "Making Sense of Treatment," which returns on June 11th and consistently draws thousands of viewers from around the world! International myeloma experts Drs. Brian Durie, Ola Landgren, Joseph Mikhael, and Antonio Palumbo will debate and discuss the latest advances in myeloma research and treatment. CLICK HERE for more information.

Member Event: Red House Carnival in Somerville, Massachusetts

The Red House Carnival fundraiser will be held on Friday, June 6th in Somerville, Massachusetts. Hosted by Julianne Stafford in memory of her father, the event will feature carnival games, food, live music, and a "water pong" tournament. "My dad's superpower when fighting cancer was his triple threat in entertaining: he provided good music, good beer, and a good laugh. He also played a mean air guitar to Jimi Hendrix's 'Red House,'" said Julianne. Julianne's fundraiser, a fitting tribute to her father, will raise funds to support crucial IMF programs. CLICK HERE for information on the event.

Join Our Mailing List
12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF Hotline: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe 

 related articles